Warning: mkdir(): No space left on device in /www/wwwroot/NEW13.COM/func.php on line 127

Warning: file_put_contents(./cachefile_yuan/bjtonghetang.com/cache/56/ce972/dcdc7.html): failed to open stream: No such file or directory in /www/wwwroot/NEW13.COM/func.php on line 115
Technoderma Medicines Announces Progression of TDM-105795 Phase 1 Clinical Trial - TechnoDerma Medicines Inc.

    1. 黄瓜视频APP最新下载,91黄瓜污在线观看,黄瓜影院污免费,黄瓜视频IOS下载

      CN / EN

      News

      Technoderma Medicines Announces Progression of TDM-105795 Phase 1 Clinical Trial

      Release time: 2022-01-05 Article source: TechnoDerma

      SHANGHAI – January 5, 2022  Technoderma Medicines, Inc. (“the Company”), a clinical stage biopharmaceutical company, is pleased to report that the Company has begun recruitment for its second Phase 1 clinical trial of topical TDM-105795 in patients with Androgenetic Alopecia (AGA). This follows successful completion of a single dose escalation study (NCT04913519), in which no material clinical safety issues were demonstrated based on reporting of adverse events, local skin reactions and changes from baseline in vital signs, safety labs, and ECG.

      This second clinical trial is a 28-day multiple dose escalation study entitled, “A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group, Multi-Dose Escalation Study to evalsuate the Safety, Tolerability, and Pharmacokinetics of TDM-105795 in Healthy Male Subjects with Androgenetic Alopecia”. Its objectives are to evalsuate topical TDM-105795 repeated dose safety and toleration and its pharmacokinetics, in order to define formulation strength(s) appropriate for a proof-of-concept Phase 2 study planned to follow.

       

      網站地圖